Arlington Partners’s Novartis NVS Stock Holding History
Bought
Maintained
Sold
Other funds holding NVS
Arlington Partners's NVS Position: Q3 2026 in Review
Arlington Partners sold out of Novartis (NVS) in Q3 2026, closing a stake of 1,579 shares — an estimated $247K sold.
Arlington Partners first reported a position in NVS in Q1 2021 and held it in 16 quarters. The position peaked at $5.08M in Q3 2025. 1,548 funds tracked by Wall St. Rank hold NVS as of Q3 2026.
- Arlington Partners reported no remaining Novartis position as of Q3 2026 after selling out during the quarter.
- Arlington Partners sold 1,579 Novartis shares in Q3 2026, an estimated $247K.
- Arlington Partners first reported a position in Novartis in Q1 2021 and held it in 16 quarters.
- Arlington Partners's Novartis position peaked at $5.08M in Q3 2025.
- 1,548 funds tracked by Wall St. Rank held Novartis as of Q3 2026.
Based on Arlington Partners's 13F filing for Q3 2026, filed 20 Oct 2026.